The global sentinel node biopsy market is increasing pervasively over the last decade. The increasing prevalence of various types of cancer, such as breast cancer, melanoma, colon cancer, and others, acts as a major driving force for the market. Also, the growing emphasis on women's healthcare impacts market growth significantly. The risk factors of cancer are equally contributing to the market growth. Moreover, the rising demand for early diagnosis and treatment of cancer accelerates the market demand.
According to Market Research Future (MRFR), the global sentinel node biopsy market is forecasted to garner significant gains by 2023, growing at a CAGR of 5.1% during the assessment period (2017 – 2023). Technological advances that transpired in the field are fostering the market growth. Besides, the market penetration of advanced biopsy devices enhances the growth of the market. The rapidly improving global economy is another key growth driver, enabling access to improved healthcare.
Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5582
Additionally, factors such as the increasing numbers of biopsy procedures and rising demand for new techniques for the diagnosis of chronic diseases propel the growth of the market. Changing lifestyles led by the growing urbanization provide significant impetus to the market growth. Also, extensive research in the field of reproductive health and diseases boost the market. Furthermore, increasing healthcare expenditure and the overall growth of the healthcare industry influence the growth of the market.
Conversely, factors such as complications associated with the biopsy and the lack of awareness among women are the major growth impeders of the sentinel node biopsy market. Adversely, the increasing availability of this biopsy procedure in the developing regions would support the growth of the market. Also, new products and services available and the presence of major market players are estimated to provide massive impetus to the market growth, filling up the demand-supply gap.
Key players leading the global sentinel node biopsy market include Devicor Medical Products, Inc. (Germany), C. R. Bard, Inc. (U.S.), Hilfe Engineering Corporation (India), Intramedical Imaging LLC (U.S.), KUB Technologies, Inc. (U.S.), Surgic Eye (Germany), and Navidea Biopharmaceuticals, Inc. (U.S.) among others.
Global Sentinel Node Biopsy Market- Segments
The report is segmented into four main dynamics to widen the scope of understanding,
- By Product: Breast Localization Wire, Tissue Marker, Gamma Probe, Drainage Catheters, and others.
- By Indication: Breast Cancer, Melanoma, Colon Cancer, Esophageal Cancer, and others.
- By End-user: Hospitals Clinics, Diagnostic Centers, and others.
- By Regions: Americas, Europe, Asia-Pacific, Middle East Africa, and Rest-of-the-World.
North America dominates the global sentinel node biopsy market. The market growth attributes to the extensive uptake of technologically advanced medical devices, increasing support for RD activities from the governments and private entities, and high expenditures for health care. Also, the rising prevalence of cancer acts as a key driving force in substantiating market growth. Furthermore, rising government support and initiatives drive the growth of the sentinel node biopsy market in North America.
Get Access Full Report @ https://www.marketresearchfuture.com/reports/sentinel-node-biopsy-market-5582
Europe has emerged as another lucrative market for sentinel node biopsy due to the increasing emphasis on advancing the diagnostic processes. The ongoing research and development activities in the field of oncology encouraged by the growing numbers of reported cancer cases drive the regional market growth significantly. Besides, rising government support for RD activities with the increased funding alongside the rising numbers of specialty service centers provides impetus to the market growth in the region.
The Asia Pacific sentinel node biopsy market is growing rapidly, mainly due to the presence of a highly skilled workforce. Increasing demand for biopsy procedures in hospitals and specialty care centers drive the growth of the regional market. India and China exhibit enormous growth opportunities due to the continually rising occurrences of cancer cases. Furthermore, factors such as the augmenting demand for early diagnosis and treatment for breast cancer in women are expected to fuel the growth of the APAC sentinel node biopsy market.